
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. (RNAC)
WebsitePrice
Market cap
Next catalystExpected 2H 2026in vivo BCMA-directed CAR-T program using Descartes-08 mRNA and WestGene tLNPs · Trial initiationCompany source ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
Partner / License out
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved